ATLANTA--(BUSINESS WIRE)--Sept. 15, 2006--MIV Therapeutics (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, has announced that David J. Cohen, M.D., M.Sc., has joined the Company's Scientific Advisory Board, where he will help guide the Company's clinical trials and other key research programs.
